WNK (With No Lysine [K]) kinases comprise a unique branch of the human kinome that appear to be responsible for a wide variety of cellular functions. Mutations of these genes cause human hypertension and have identified them as part of a novel signaling mechanism in the kidney. WNK1, WNK3, and WNK4 have distinct properties to stimulate or inhibit salt transport, effects that can be modified based on physiological need. The WNK signaling complex hypothesis postulates that the kidney specific effects of WNK kinases are mediated by the unique convergence of four members of the WNK kinase family within distal nephron cells. The proposed experiments will elucidate the nature of this complex by demonstrating where the WNK kinases are expressed along the nephron, how WNK3 and WNK4 interact to regulate salt transport, and how a kidney-specific kinase-deficient WNK signals to WNK3 in kidney. It has been demonstrated recently that WNK kinases also mediate aldosterone signaling to the thiazide-sensitive salt transporter. The proposed work will address the mechanisms involved. This work will involve heterologous expression in Xenopus oocytes and epithelial cells.
The second aim will move the work toward more physiologically relevant model systems by examining the effects of increased abundance of the thiazide-sensitive transporter and by developing models to delete or increase expression of WNK kinases specifically along the distal nephron. Specifically, they will test the results of cell-specific knockout or knockin of WNK3. The results will substantially enhance both the understanding of the WNK signaling complex and provide avenues for developing drugs that enhance salt excretion without affecting potassium balance. Project Relevance: Hypertension is the most common disease in the United States. There is a large genetic component, but the nature of the genetic basis is unclear. WNK kinases regulate blood pressure in animals and humans. This work holds the possibility not only of improved understanding of blood pressure regulation but also of developing new, safer and more effective drugs to treat this important disease.

Public Health Relevance

Hypertension is the most common disorder of Americans, accounts for billions of dollars of cost, and costs millions of lives. A large portion of hypertension is related to genetics. This proposal will help unravel genetic contributions to human blood pressure variation, with the goal of finding better treatments, or better preventive maneuvers.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK051496-12A2
Application #
7988394
Study Section
Cellular and Molecular Biology of the Kidney Study Section (CMBK)
Program Officer
Ketchum, Christian J
Project Start
1998-08-01
Project End
2013-07-31
Budget Start
2010-08-26
Budget End
2011-07-31
Support Year
12
Fiscal Year
2010
Total Cost
$231,000
Indirect Cost
Name
Oregon Health and Science University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Murillo-de-Ozores, Adrián Rafael; Rodríguez-Gama, Alejandro; Bazúa-Valenti, Silvana et al. (2018) C-terminally truncated, kidney-specific variants of the WNK4 kinase lack several sites that regulate its activity. J Biol Chem 293:12209-12221
Terker, Andrew S; Castañeda-Bueno, Maria; Ferdaus, Mohammed Z et al. (2018) With no lysine kinase 4 modulates sodium potassium 2 chloride cotransporter activity in vivo. Am J Physiol Renal Physiol 315:F781-F790
Cornelius, Ryan J; Zhang, Chong; Erspamer, Kayla J et al. (2018) Dual gain and loss of cullin 3 function mediates familial hyperkalemic hypertension. Am J Physiol Renal Physiol 315:F1006-F1018
Bazúa-Valenti, Silvana; Rojas-Vega, Lorena; Castañeda-Bueno, María et al. (2018) The Calcium-Sensing Receptor Increases Activity of the Renal NCC through the WNK4-SPAK Pathway. J Am Soc Nephrol 29:1838-1848
Li, Ai-Jun; Wang, Qing; Ritter, Sue (2018) Selective Pharmacogenetic Activation of Catecholamine Subgroups in the Ventrolateral Medulla Elicits Key Glucoregulatory Responses. Endocrinology 159:341-355
Cornelius, Ryan J; Si, Jinge; Cuevas, Catherina A et al. (2018) Renal COP9 Signalosome Deficiency Alters CUL3-KLHL3-WNK Signaling Pathway. J Am Soc Nephrol 29:2627-2640
Ellison, David H (2017) Treatment of Disorders of Sodium Balance in Chronic Kidney Disease. Adv Chronic Kidney Dis 24:332-341
Ferdaus, Mohammed Z; Miller, Lauren N; Agbor, Larry N et al. (2017) Mutant Cullin 3 causes familial hyperkalemic hypertension via dominant effects. JCI Insight 2:
Cuevas, Catherina A; Su, Xiao-Tong; Wang, Ming-Xiao et al. (2017) Potassium Sensing by Renal Distal Tubules Requires Kir4.1. J Am Soc Nephrol 28:1814-1825
Castañeda-Bueno, Maria; Arroyo, Juan Pablo; Zhang, Junhui et al. (2017) Phosphorylation by PKC and PKA regulate the kinase activity and downstream signaling of WNK4. Proc Natl Acad Sci U S A 114:E879-E886

Showing the most recent 10 out of 61 publications